MarketPeel
Pricing
…
CHIEF FINANCIAL OFFICER
Benjamin Hohl
Thu, Feb 12, 2026
Feb 12
received an award in ELVN
25,000 shares @ $0.00
Increased holdings by +69.40%
ELVNEnliven Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W+0.48%
1M+12.97%
3M+40.65%
6M—
1Y—

Recent insider activity at ELVN

Aug 17Benjamin HohlSold$270.17kAug 17Helen Louise CollinsSold$227.65kAug 17Helen Louise CollinsSold$65.28kAug 17Benjamin HohlSold$82.38kAug 4Mika K. DerynckSold$9.56mJul 17Benjamin HohlSold$134.14kJul 17Benjamin HohlSold$140.82kJul 17Benjamin HohlSold$16.19k
Full ELVN profile →Benjamin Hohl’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback